Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
AGNG
83
HOLDINGS
13%
ALSO IN CANC
CANC
55
HOLDINGS
20%
ALSO IN AGNG
SECTOR DRIFT (AGNG minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in AGNG |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 4.1% | 5.3% | 4.1% |
|
ABBVIE INC | 3.8% | 4.0% | 3.8% |
|
MERCK & CO. INC. | 3.4% | 5.2% | 3.4% |
|
BRISTOL-MYERS SQUIBB CO | 2.9% | 2.7% | 2.7% |
|
BEIGENE LTD. SPONSORED ADR | 2.6% | 3.7% | 2.6% |
AGNG Overweight Relative to CANC
|
REGENERON PHARMACEUTICALS | 3.3% |
 |
ROCHE HOLDING AG-BR | 3.3% |
|
EDWARDS LIFESCIENCES CORP | 3.2% |
|
WELLTOWER, INC. | 3.1% |
 |
MEDTRONIC PLC | 3.0% |
 |
NOVO NORDISK A/S-B | 2.9% |
|
SANDOZ GROUP AG | 2.8% |
|
VENTAS INC | 2.7% |
 |
UCB SA | 2.7% |
|
GENMAB A/S | 2.4% |
AGNG Underweight Relative to CANC
|
GENMAB A/S SPONSORED ADR | -5.7% |
|
REVOLUTION MEDICINES, INC. | -5.2% |
|
COGENT BIOSCIENCES INC | -4.5% |
|
NOVARTIS AG | -4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.1% |
|
BRIDGEBIO PHARMA, INC. | -3.0% |
|
HALOZYME THERAPEUTICS INC | -2.8% |
|
EXELIXIS INC | -2.5% |
|
ENLIVEN THERAPEUTICS, INC. | -2.4% |
|
IMMUNOME, INC. | -2.3% |